Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic Acid Compared to Metformin for Gestational Diabetes
NCT04407650Phase 4Terminated
- Sponsor
- King's College London
- Start
- Jun 2021
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ursodeoxycholic acid in gestational diabetes mellitus (GDM), sponsored by King's College London. Started Jun 2021; status: terminated.
02
Drugs
ursodeoxycholic acid
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT04407650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04407650.